ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds.

May 6, 2005

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

Pennsylvania Issues RFPs For Cancer Control Program

October 21, 1983

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011